Lyrinel XL use in children

The licence for Lyrinel XL (oxybutynin prolonged release) has been extended to include use in children over six years. Previously, use in children under 18 years was not recommended.

The recommended starting dose for children over six years is 5mg once daily, increasing by 5mg increments up to a maximum of 15mg once daily. The safety and efficacy of Lyrinel XL has not been established in patients under six years.

Further information: Janssen-Cilag Ltd 01494 567444

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Drug shortages - live tracker

Drug shortages - live tracker

Added: glycopyrronium bromide, Sytron and tolterodine.

Free on MIMS Learning: coronavirus resources

Free on MIMS Learning: coronavirus resources

Free learning resources for healthcare professionals...

COVID-19 outbreak: continue ARBs and ACE inhibitors, GPs urged

COVID-19 outbreak: continue ARBs and ACE inhibitors, GPs urged

Prescribers should not stop angiotensin receptor blockers...